My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring ...

The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...

Recent studies show that HIV patients are 10 to 20 times more likely to develop lymphoma compared to individuals without HIV.

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

Last week, doctors diagnosed the former Nickerson basketball star with Stage 4 Hodgkin's Lymphoma. She's set to begin chemo treatments this week.

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...